NSE ScannerComparison · NSE · data 2026-11-01
Fredun Pharmaceuticals Ltd. vs Sai Parenterals Limited
In plain words
Size: Sai Parenterals Limited is about 1 times the market value of Fredun Pharmaceuticals Ltd..
Return on equity: Fredun Pharmaceuticals Ltd. 15.6% vs Sai Parenterals Limited 4.9%.
Differences in the numbers, not a recommendation of either stock.
Side by side
| FREDUN | SAIPARENT | |
|---|---|---|
| Price | ₹1,367 | ₹521.95 |
| Market cap | ₹2,259 cr | ₹2,302 cr |
| P/E | 49.7 | — |
| P/B | — | — |
| ROE | 15.6% | 4.9% |
| ROCE | 33.0% | 5.8% |
| Debt / equity | 0.87 | 0.96 |
| Operating margin | 13.4% | — |
| Dividend yield | 0.02% | 0.00% |
| Sales growth, 3 years (yearly) | 32.5% | 57.9% |
| Profit growth, 3 years (yearly) | 44.5% | 48.3% |
| 1-year return | -11.2% | 30.5% |
| Revenue, last 12 months | ₹748 cr | — |
| Net profit, last 12 months | ₹44 cr | — |
| Latest quarter | — | Sept 2026 |
| Quarter net profit | — | ₹11 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | — | 51.16% |
| Health check | Strong (6.7/10) | Strong (6.7/10) |
Common questions
Which earns a higher return on equity?
Fredun Pharmaceuticals Ltd. (15.6% against 4.9%).
Which carries more debt?
Sai Parenterals Limited has the higher debt-to-equity ratio (0.96 against 0.87).